Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Advanced Heart Failure & Transplant Cardiology, University of Nebraska Medical Center, Omaha, NE, USA.
Cardiovasc Ultrasound. 2024 Aug 8;22(1):10. doi: 10.1186/s12947-024-00330-2.
From its inception as a two-dimensional snapshot of the beating heart, echocardiography has become an indelible part of cardiovascular diagnostics. The integration of ultrasound enhancing agents (UEAs) marks a pivotal transition, enhancing its diagnostic acumen beyond myocardial perfusion. These agents have refined echocardiography's capacity to visualize complex cardiac anatomy and pathology with unprecedented clarity, especially in non-coronary artery disease contexts. UEAs aid in detailed assessments of myocardial viability, endocardial border delineation in left ventricular opacification, and identification of intracardiac masses. Recent innovations in UEAs, accompanied by advancements in echocardiographic technology, offer clinicians a more nuanced view of cardiac function and blood flow dynamics. This review explores recent developments in these applications and future contemplated studies.
从最初作为心脏跳动的二维静态图像，超声心动图已经成为心血管诊断不可或缺的一部分。超声增强剂（UEAs）的整合标志着一个关键的转变，它将超声心动图的诊断敏锐度提高到心肌灌注之外。这些试剂提高了超声心动图以空前的清晰度显示复杂心脏解剖结构和病理学的能力，尤其是在非冠状动脉疾病的情况下。UEAs 有助于对心肌活力、左心室显影时心内膜边界的详细评估，以及心脏内部肿块的识别。UEAs 的最新创新，伴随着超声心动图技术的进步，为临床医生提供了对心脏功能和血流动力学更细致的观察。这篇综述探讨了这些应用的最新进展以及未来预期的研究。
